FELICIA HUDDLESTON: Open Payments
NPI 1063772515 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 17 payments from 5 companies in 2025. Trend: 2023 $23 · 2024 $13 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $169 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Boston Scientific Corporation | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, Infinion 16, HETLIOZ.
Industry payments across TX — which companies pay providers there.
